Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001571049-15-004625
Filing Date
2015-05-26
Accepted
2015-05-26 21:16:51
Documents
1
Period of Report
2015-05-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT t1501260_x4.html 4  
1 OWNERSHIP DOCUMENT t1501260_x4.xml 4 3962
  Complete submission text file 0001571049-15-004625.txt   5440
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address
HENNEY CHRISTOPHER S (Reporting) CIK: 0001242880 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 15890794